ArticleFrontiers in immunology2023

Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement.

Hongzhi Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.